IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation

Journal of Immunology

Volumn 194, Issue 5, 2015, Pages 2369-2379

  Paschall, Amy V ^a,b   Zhang, Ruihua ^c   Qi, Chen Feng ^d   Bardhan, Kankana ^a   Peng, Liang ^c   Lu, Geming ^c   Yang, Jianjun ^c   Merad, Miriam ^c   McGaha, Tracy ^a   Zhou, Gang ^a   Mellor, Andrew ^a   Abrams, Scott I ^e   Morse, Herbert C ^d   Ozato, Keiko ^f   Xiong, Huabao ^c   Liu, Kebin ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD131 ANTIGEN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; CD11B ANTIGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON REGULATORY FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BONE MARROW CELL; CD11B+ GR1+ MYELOID DERIVED SUPPRESSOR CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CONTROLLED STUDY; GENE; GENE OVEREXPRESSION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IN VIVO STUDY; IRF8 GENE; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SUPPRESSOR CELL; T LYMPHOCYTE; ADOPTIVE TRANSFER; ANIMAL; CELL PROLIFERATION; CHIMERA; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; SIGNAL TRANSDUCTION; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD11B; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CHIMERA; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON REGULATORY FACTORS; MICE; MYELOID CELLS; MYELOPOIESIS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 84924386399     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1402412     Document Type: Article

References (73)

1. Okabe, Y., and R. Medzhitov. 2014. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell 157: 832-844.
2. Wynn, T. A., A. Chawla, and J. W. Pollard. 2013. Macrophage biology in development, homeostasis and disease. Nature 496: 445-455.
3. Gabrilovich, D. I., and S. Nagaraj. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9: 162-174.
4. Gabrilovich, D. I., S. Ostrand-Rosenberg, and V. Bronte. 2012. Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12: 253-268.
5. Metcalf, D. 1989. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells. Nature 339: 27-30.
6. Milanovic, M., G. Terszowski, D. Struck, O. Liesenfeld, and D. Carstanjen. 2008. IFN consensus sequence binding protein (Icsbp) is critical for eosinophil development. J. Immunol. 181: 5045-5053.
7. Tsujimura, H., T. Tamura, and K. Ozato. 2003. Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells. J. Immunol. 170: 1131-1135.
8. Jaiswal, H., M. Kaushik, R. Sougrat, M. Gupta, A. Dey, R. Verma, K. Ozato, and P. Tailor. 2013. Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8α+ dendritic cell development. J. Immunol. 191: 5993-6001.
9. Wang, H., M. Yan, J. Sun, S. Jain, R. Yoshimi, S. M. Abolfath, K. Ozato, W. G. Coleman, Jr., A. P. Ng, D. Metcalf, et al. 2014. A reporter mouse reveals lineage-specific and heterogeneous expression of IRF8 during lymphoid and myeloid cell differentiation. J. Immunol. 193: 1766-1777.
10. Kanno, Y., B. Z. Levi, T. Tamura, and K. Ozato. 2005. Immune cell-specific amplification of interferon signaling by the IRF-4/8-PU.1 complex. J. Interferon Cytokine Res. 25: 770-779.
11. Tenen, D. G., R. Hromas, J. D. Licht, and D. E. Zhang. 1997. Transcription factors, normal myeloid development, and leukemia. Blood 90: 489-519.
12. Satpathy, A. T., C. G. Briseño, X. Cai, D. G. Michael, C. Chou, S. Hsiung, D. Bhattacharya, N. A. Speck, and T. Egawa. 2014. Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder. Blood 123: 2968-2977.
13. Tamura, T., T. Nagamura-Inoue, Z. Shmeltzer, T. Kuwata, and K. Ozato. 2000. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13: 155-165.
14. Novershtern, N., A. Subramanian, L. N. Lawton, R. H. Mak, W. N. Haining, M. E. McConkey, N. Habib, N. Yosef, C. Y. Chang, T. Shay, et al. 2011. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell 144: 296-309.
15. Shivdasani, R. A., and S. H. Orkin. 1996. The transcriptional control of hematopoiesis. Blood 87: 4025-4039.
16. Singh, H., R. P. DeKoter, and J. C. Walsh. 1999. PU.1, a shared transcriptional regulator of lymphoid and myeloid cell fates. Cold Spring Harb. Symp. Quant. Biol. 64: 13-20.
17. DeKoter, R. P., J. C. Walsh, and H. Singh. 1998. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J. 17: 4456-4468.
18. Iwasaki, H., and K. Akashi. 2007. Myeloid lineage commitment from the hematopoietic stem cell. Immunity 26: 726-740.
19. Kurotaki, D., N. Osato, A. Nishiyama, M. Yamamoto, T. Ban, H. Sato, J. Nakabayashi, M. Umehara, N. Miyake, N. Matsumoto, et al. 2013. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation. Blood 121: 1839-1849.
20. Feinberg, M. W., A. K. Wara, Z. Cao, M. A. Lebedeva, F. Rosenbauer, H. Iwasaki, H. Hirai, J. P. Katz, R. L. Haspel, S. Gray, et al. 2007. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 26: 4138-4148.
21. Alder, J. K., R. W. Georgantas, III, R. L. Hildreth, I. M. Kaplan, S. Morisot, X. Yu, M. McDevitt, and C. I. Civin. 2008. Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo. J. Immunol. 180: 5645-5652.
22. Hanna, R. N., L. M. Carlin, H. G. Hubbeling, D. Nackiewicz, A. M. Green, J. A. Punt, F. Geissmann, and C. C. Hedrick. 2011. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes. Nat. Immunol. 12: 778-785.
23. Kelly, L. M., U. Englmeier, I. Lafon, M. H. Sieweke, and T. Graf. 2000. MafB is an inducer of monocytic differentiation. EMBO J. 19: 1987-1997.
24. Hegde, S. P., J. Zhao, R. A. Ashmun, and L. H. Shapiro. 1999. c-Maf induces monocytic differentiation and apoptosis in bipotent myeloid progenitors. Blood 94: 1578-1589.
25. Nguyen, H. Q., B. Hoffman-Liebermann, and D. A. Liebermann. 1993. The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage. Cell 72: 197-209.
26. Savitsky, D., T. Tamura, H. Yanai, and T. Taniguchi. 2010. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 59: 489-510.
27. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26: 535-584.
28. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19: 623-655.
29. Ikushima, H., H. Negishi, and T. Taniguchi. 2013. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb. Symp. Quant. Biol. 78: 105-116.
30. K108E mutation. Blood 124: 1894-1904.
31. Becker, A. M., D. G. Michael, A. T. Satpathy, R. Sciammas, H. Singh, and D. Bhattacharya. 2012. IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. Blood 119: 2003-2012.
32. Tamura, T., and K. Ozato. 2002. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J. Interferon Cytokine Res. 22: 145-152.
33. Tamura, T., P. Thotakura, T. S. Tanaka, M. S. Ko, and K. Ozato. 2005. Identification of target genes and a unique cis element regulated by IRF-8 in developing macrophages. Blood 106: 1938-1947.
34. Dror, N., M. Alter-Koltunoff, A. Azriel, N. Amariglio, J. Jacob-Hirsch, S. Zeligson, A. Morgenstern, T. Tamura, H. Hauser, G. Rechavi, et al. 2007. Identification of IRF-8 and IRF-1 target genes in activated macrophages. Mol. Immunol. 44: 338-346.
35. Hambleton, S., S. Salem, J. Bustamante, V. Bigley, S. Boisson-Dupuis, J. Azevedo, A. Fortin, M. Haniffa, L. Ceron-Gutierrez, C. M. Bacon, et al. 2011. IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 365: 127-138.
36. Holtschke, T., J. Löhler, Y. Kanno, T. Fehr, N. Giese, F. Rosenbauer, J. Lou, K. P. Knobeloch, L. Gabriele, J. F. Waring, et al. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87: 307-317.
37. Tailor, P., T. Tamura, H. C. Morse, III, and K. Ozato. 2008. The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood 111: 1942-1945.
38. Waight, J. D., C. Netherby, M. L. Hensen, A. Miller, Q. Hu, S. Liu, P. N. Bogner, M. R. Farren, K. P. Lee, K. Liu, and S. I. Abrams. 2013. Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. J. Clin. Invest. 123: 4464-4478.
39. Ouyang, X., R. Zhang, J. Yang, Q. Li, L. Qin, C. Zhu, J. Liu, H. Ning, M. S. Shin, M. Gupta, et al. 2011. Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation. Nat. Commun. 2: 314.
40. Feng, J., H. Wang, D. M. Shin, M. Masiuk, C. F. Qi, and H. C. Morse, III. 2011. IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools. J. Immunol. 186: 1458-1466.
41. Yamamoto, M., T. Kato, C. Hotta, A. Nishiyama, D. Kurotaki, M. Yoshinari, M. Takami, M. Ichino, M. Nakazawa, T. Matsuyama, et al. 2011. Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development. PLoS One 6: e25812.
42. Rosenbauer, F., and D. G. Tenen. 2007. Transcription factors in myeloid development: balancing differentiation with transformation. Nat. Rev. Immunol. 7: 105-117.
43. Zhao, J., H. J. Kong, H. Li, B. Huang, M. Yang, C. Zhu, M. Bogunovic, F. Zheng, L. Mayer, K. Ozato, et al. 2006. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. J. Biol. Chem. 281: 10073-10080.
44. Zhu, C., K. Rao, H. Xiong, K. Gagnidze, F. Li, C. Horvath, and S. Plevy. 2003. Activation of the murine interleukin-12 p40 promoter by functional interactions between NFAT and ICSBP. J. Biol. Chem. 278: 39372-39382.
45. Sinha, P., O. Chornoguz, V. K. Clements, K. A. Artemenko, R. A. Zubarev, and S. Ostrand-Rosenberg. 2011. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood 117: 5381-5390.
46. Gabriele, L., J. Phung, J. Fukumoto, D. Segal, I. M. Wang, P. Giannakakou, N. A. Giese, K. Ozato, and H. C. Morse, III. 1999. Regulation of apoptosis in myeloid cells by interferon consensus sequence-binding protein. J. Exp. Med. 190: 411-421.
47. Yang, J., X. Hu, M. Zimmerman, C. M. Torres, D. Yang, S. B. Smith, and K. Liu. 2011. Cutting edge: IRF8 regulates Bax transcription in vivo in primary myeloid cells. J. Immunol. 187: 4426-4430.
48. Yang, D., S. Wang, C. Brooks, Z. Dong, P. V. Schoenlein, V. Kumar, X. Ouyang, H. Xiong, G. Lahat, A. Hayes-Jordan, et al. 2009. IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression. Cancer Res. 69: 1080-1088.
49. Hu, X., K. Bardhan, A. V. Paschall, D. Yang, J. L. Waller, M. A. Park, A. Nayak-Kapoor, T. A. Samuel, S. I. Abrams, and K. Liu. 2013. Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer. J. Biol. Chem. 288: 19103-19115.
50. Jiao, J., A. C. Dragomir, P. Kocabayoglu, A. H. Rahman, A. Chow, D. Hashimoto, M. Leboeuf, T. Kraus, T. Moran, G. Carrasco-Avino, et al. 2014. Central role of conventional dendritic cells in regulation of bone marrow release and survival of neutrophils. J. Immunol. 192: 3374-3382.
51. Pathak, S., S. Ma, V. Shukla, and R. Lu. 2013. A role for IRF8 in B cell anergy. J. Immunol. 191: 6222-6230.
52. Bunt, S. K., L. Yang, P. Sinha, V. K. Clements, J. Leips, and S. Ostrand-Rosenberg. 2007. Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res. 67: 10019-10026.
53. Serafini, P., R. Carbley, K. A. Noonan, G. Tan, V. Bronte, and I. Borrello. 2004. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res. 64: 6337-6343.
54. Waight, J. D., Q. Hu, A. Miller, S. Liu, and S. I. Abrams. 2011. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS One 6: e27690.
55. Bayne, L. J., G. L. Beatty, N. Jhala, C. E. Clark, A. D. Rhim, B. Z. Stanger, and R. H. Vonderheide. 2012. Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer. Cancer Cell 21: 822-835.
56. Marigo, I., E. Bosio, S. Solito, C. Mesa, A. Fernandez, L. Dolcetti, S. Ugel, N. Sonda, S. Bicciato, E. Falisi, et al. 2010. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 32: 790-802.
57. Pylayeva-Gupta, Y., K. E. Lee, C. H. Hajdu, G. Miller, and D. Bar-Sagi. 2012. Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia. Cancer Cell 21: 836-847.
58. Iwasaki, A., and R. Medzhitov. 2010. Regulation of adaptive immunity by the innate immune system. Science 327: 291-295.
59. Rutkowski, M. R., T. L. Stephen, and J. R. Conejo-Garcia. 2012. Anti-tumor immunity: myeloid leukocytes control the immune landscape. Cell. Immunol. 278: 21-26.
60. Schenten, D., and R. Medzhitov. 2011. The control of adaptive immune responses by the innate immune system. Adv. Immunol. 109: 87-124.
61. Wermeling, F., R. M. Anthony, F. Brombacher, and J. V. Ravetch. 2013. Acute inflammation primes myeloid effector cells for anti-inflammatory STAT6 signaling. Proc. Natl. Acad. Sci. USA 110: 13487-13491.
62. Sonda, N., F. Simonato, E. Peranzoni, B. Calì, S. Bortoluzzi, A. Bisognin, E. Wang, F. M. Marincola, L. Naldini, B. Gentner, et al. 2013. miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis. Immunity 38: 1236-1249.
63. Ostrand-Rosenberg, S. 2013. Looking to the future of cancer immunotherapy: many questions to answer and many therapeutic opportunities. Cancer Immunol. Immunother. 62: 1-2.
64. Youn, J. I., V. Kumar, M. Collazo, Y. Nefedova, T. Condamine, P. Cheng, A. Villagra, S. Antonia, J. C. McCaffrey, M. Fishman, et al. 2013. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat. Immunol. 14: 211-220.
65. Pyonteck, S. M., L. Akkari, A. J. Schuhmacher, R. L. Bowman, L. Sevenich, D. F. Quail, O. C. Olson, M. L. Quick, J. T. Huse, V. Teijeiro, et al. 2013. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19: 1264-1272.
66. Clemens, R. A., L. E. Lenox, T. Kambayashi, N. Bezman, J. S. Maltzman, K. E. Nichols, and G. A. Koretzky. 2007. Loss of SLP-76 expression within myeloid cells confers resistance to neutrophil-mediated tissue damage while maintaining effective bacterial killing. J. Immunol. 178: 4606-4614.
67. Clausen, B. E., C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster. 1999. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8: 265-277.
68. Sissons, J. R., J. J. Peschon, F. Schmitz, R. Suen, M. Gilchrist, and A. Aderem. 2012. Cutting edge: microRNA regulation of macrophage fusion into multinucleated giant cells. J. Immunol. 189: 23-27.
69. Lalani, A. I., C. R. Moore, C. Luo, B. Z. Kreider, Y. Liu, H. C. Morse, III, and P. Xie. 2015. Myeloid cell TRAF3 regulates immune responses and inhibits inflammation and tumor development in mice. J. Immunol. 194: 334-348.
70. Gautier, E. L., A. Chow, R. Spanbroek, G. Marcelin, M. Greter, C. Jakubzick, M. Bogunovic, M. Leboeuf, N. van Rooijen, A. J. Habenicht, et al. 2012. Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity. J. Immunol. 189: 2614-2624.
71. Stewart, T. J., K. M. Greeneltch, J. E. Reid, D. J. Liewehr, S. M. Steinberg, K. Liu, and S. I. Abrams. 2009. Interferon regulatory factor-8 modulates the development of tumour-induced CD11b+Gr-1+ myeloid cells. J. Cell. Mol. Med. 13: 3939-3950.
72. Siegel, R. M., F. K. Chan, H. J. Chun, and M. J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immunol. 1: 469-474.
73. Hu, X., D. Yang, M. Zimmerman, F. Liu, J. Yang, S. Kannan, A. Burchert, Z. Szulc, A. Bielawska, K. Ozato, et al. 2011. IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. Cancer Res. 71: 2882-2891.